Immunobiology of Dendritic Cells in Crohn's Disease
克罗恩病树突状细胞的免疫生物学
基本信息
- 批准号:7023429
- 负责人:
- 金额:$ 18.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-09-30 至 2007-08-31
- 项目状态:已结题
- 来源:
- 关键词:Crohn&aposs diseaseantigen presentationcell biologycell differentiationclinical researchdendritic cellsflow cytometryhuman subjectimmune responseimmunocytochemistryimmunoregulationinflammationintestinal mucosamass spectrometryphagocytosisphenotypereceptor expressionstromal cellstransforming growth factors
项目摘要
DESCRIPTION (provided by applicant): The regulation of macrophage and dendritic cell (DC) responses to ingested antigens and luminal microorganisms is a critical component of homeostasis in the intestinal muosa. We have reported that resident macrophages in normal human intestine are profoundly down-regulated for inflammatory responses due to exposure to mucosal stromal cell products, particularly TGF-beta (Smythies, et al. J. Clin. Invest. 115:66, '05). This down-regulation likely contributes to the near absence of inflammation in normal small intestine. Regarding intestinal DCs, our preliminary results suggest that resident DCs in normal human small intestinal mucosa are less prevalent, express lower levels of maturation and activation markers, and release lower levels of cytokines than DCs in the non-inflamed mucosa of patients with Crohn's disease. Thus, DCs in normal intestinal mucosa, like intestinal macrophages, may be down-regulated for inflammatory activity, suggesting that intestinal DCs also contribute to the low level of inflammation in normal intestinal mucosa, DCs in non-inflamed intestinal mucosa of patients with Crohn's disease may be less stringently downregulated and thus able to promote inflammation. Our preliminary results suggest that intestinal lamina propria stroma releases factors that down-regulate the maturity and inflammatory potential of monocyte-derived DCs (M-DCs), indicating a possible mechanism by which intestinal DCs, which likely are derived from the circulation, become down-regulated for inflammatory activity in normal intestinal mucosa. Therefore, to confirm and extend our preliminary results, we propose in this application to test the following two hypotheses: (1) Primary human intestinal DCs from patients with Crohn's disease are more prevalent, more mature and more activated than DCs from normal intestine and (2) The reduced level of maturity and activation of DCs in normal intestinal mucosa compared to that of DCs in Crohn's disease intestinal mucosa is due to intestinal stromal factors on DCs recruited from the circulation into the lamina propria. Using homologous primary intestinal DCs and M-DCs, we propose to test the above hypotheses with the following two Specific Aims:
1. Determine whether small intestinal DCs from patients with Crohn's disease are more prevalent, more mature and more activated than DCs from normal intestine, enabling DCs from Crohn's disease tissue to present antigen more efficiently than DCs from normal intestinal tissue.
2. Determine whether the reduced level of maturity and activation of DCs from normal intestinal mucosa compared to DCs from Crohn's disease mucosa is due to the effects of intestinal stromal factors on DCs.
描述(由申请方提供):巨噬细胞和树突状细胞(DC)对摄入抗原和管腔微生物应答的调节是肠粘膜内稳态的关键组成部分。我们已经报道,由于暴露于粘膜基质细胞产物,特别是TGF-β,正常人肠中的常驻巨噬细胞对于炎症反应被显著下调(Smythies等人,J.Clin.Invest.2005,2006)。115:66,'05)。这种下调可能有助于正常小肠中几乎没有炎症。关于肠道树突状细胞,我们的初步结果表明,居民在正常人小肠粘膜的树突状细胞是不太普遍,表达较低水平的成熟和活化标志物,并释放较低水平的细胞因子比在克罗恩病患者的非炎症粘膜的树突状细胞。因此,正常肠粘膜中的DC,像肠巨噬细胞一样,可以下调炎症活性,表明肠DC也有助于正常肠粘膜中的低水平炎症,克罗恩病患者的非炎症肠粘膜中的DC可能不太严格地下调,因此能够促进炎症。我们的初步研究结果表明,肠固有层基质释放因子,下调单核细胞衍生的DC(M-DC)的成熟和炎症潜力,表明一种可能的机制,肠道DC,这可能是来自循环,成为下调正常肠粘膜的炎症活动。因此,为了证实和扩展我们的初步结果,我们在本申请中提出测试以下两个假设:(1)来自克罗恩病患者的原代人肠DC更普遍,比来自正常肠的DC更成熟和更活化,和(2)与克罗恩病肠粘膜中的DC相比,正常肠粘膜中的DC的成熟和活化水平降低是由于肠基质因子对从循环募集到固有层的DC的影响。使用同源原代肠道DC和M-DC,我们提出用以下两个特定目的来检验上述假设:
1.确定来自克罗恩病患者的小肠DC是否比来自正常肠的DC更普遍、更成熟和更活化,使来自克罗恩病组织的DC比来自正常肠组织的DC更有效地呈递抗原。
2.确定与克罗恩病粘膜的DC相比,正常肠粘膜的DC成熟和活化水平降低是否是由于肠基质因子对DC的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LESLEY E SMYTHIES其他文献
LESLEY E SMYTHIES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LESLEY E SMYTHIES', 18)}}的其他基金
Mucosal TGF-Beta/IL-6 Axis in the Regulation of T Cell Function
粘膜 TGF-β/IL-6 轴在 T 细胞功能调节中的作用
- 批准号:
7707052 - 财政年份:2009
- 资助金额:
$ 18.19万 - 项目类别:
Mucosal TGF-Beta/IL-6 Axis in the Regulation of T Cell Function
粘膜 TGF-β/IL-6 轴在 T 细胞功能调节中的作用
- 批准号:
7860420 - 财政年份:2009
- 资助金额:
$ 18.19万 - 项目类别:
Immunobiology of Dendritic Cells in Crohn's Disease
克罗恩病树突状细胞的免疫生物学
- 批准号:
7140648 - 财政年份:2005
- 资助金额:
$ 18.19万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 18.19万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 18.19万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 18.19万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 18.19万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 18.19万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 18.19万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 18.19万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 18.19万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 18.19万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 18.19万 - 项目类别:














{{item.name}}会员




